Global Newborn Screening Test Market Size, Trends, and Analysis- Forecasts To 2026 By Type of Test (Dry Blood Spot, Hearing Screen Test, Critical Congenital Heart Disease (CCHD)), By Technology (Electrophoresis, Tandem Mass Spectrometry, DNA Assays, Pulse Oximetry, Enzyme Based Assays), By Product (Reagents & Assay Kits, Instruments), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Newborn screening is a type of screening procedure for newborns that are required to rule out severe conditions such as metabolic and genetic disorders and potentially lethal conditions that are not evident at birth. These tests allow health providers to recognize and treat certain disorders that enable a child with normal development to grow up healthy. The growth of the market is expected to be driven by the rising number of newborn cases with congenital disease and increasing awareness of CCHD screening from 2021 to 2026. Moreover, an increasing number of neonatal diseases such as congenital hypothyroidism, hearing loss in newborns, and the rising number of newborn screening programs worldwide are likely to bring new opportunities to the global newborn screening market. Furthermore, numerous government policies coupled with increasing awareness of the screening benefits to increase the market exponentially from 2021 to 2026.
Dry blood spot, hearing screen test and critical congenital heart disease (CCHD) are the different types of the test of the newborn screening market. The dry blood segment is anticipated to hold the largest market share over the predicted timeframe. Blood collection from the newborn's heel on the screening card is called a dried blood spot test (DBS) to diagnose more than 50 conditions within 24-48 hours of birth.
Reagents & assay kits, and instruments are the market segment according to the product & service outlook. As of 2020, the instrument segment held the largest market share. This can be due to the large use of screening instruments across the globe for newborn disease diagnosis.
Electrophoresis, tandem mass spectrometry, DNA assays, pulse oximetry, and enzyme-based assays are key technology segments. In 2019, technology-based tandem mass spectrometry will grow at the highest CAGR value from 2021 to 2026, owing to the high sensitivity of the technology for screening metabolic disorders.
Over the expected timeline, the North American region is projected to have the highest share in the market from 2021-2026. This can be attributed to the rising neonatal population and increasing demand for screening tests and procedures. According to WHO, genetic disease is the leading cause of child deaths in the United States, which has accounted for nearly 20% of the overall annual infant mortality rate. On the other hand, the Asia Pacific region will be the fastest-growing region, owing to the presence of a huge neonatal population and the launch of new & advanced screening technologies to propel the market growth.
Covidien Plc., Bio-Rad Laboratories, Masimo Corporation, Natus, Medical, GE Lifesciences, AB SCIEX, Agilent Technologies, Waters Corporation, Trivitron, Healthcare, and PerkinElmer Inc, among others are the major players competing in this market.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Newborn Screening Test Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Newborn Screening Test Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?